ArticleThe Journal of dermatology2025
Prognostic Significance of TBX21 and GATA3 Subtype Classification in Indolent Adult T-Cell Leukemia-Lymphoma With Cutaneous Lesions.
Article in The Journal of dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Immunoprofiling Reveals GATA3 as a Prognostic Marker in Transformed Mycosis Fungoides.The Journal of dermatology · 2026Article
- Liver Cirrhosis Caused by Food-Borne Zoonotic Fasciola gigantica in Cattle in Bangladesh: Pathology and Immunological Orchestra.Immunity, inflammation and disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Chronic-type adult T-cell leukemia-lymphoma (ATL) without unfavorable prognostic factors and smoldering-type ATL are classified as indolent ATL. Indolent ATL patients often present with cutaneous lesions, but their clinical course is diverse. Smoldering-type ATL presenting with tumoral cutaneous lesions and without lung involvement has a poor prognosis and is designated as primary cutaneous tumoral (PCT) type. Indolent ATL prognostic index (iATL-PI) based on the soluble IL-2 receptor levels and its modified version have been proposed. Peripheral T-cell lymphoma, not otherwise specified (PTCL NOS) is classified into two prognostic subtypes, PTCL-TBX21 and PTCL-GATA3, using an immunohistochemistry (IHC) algorithm based on TBX21/CXCR3 and GATA3/CCR4 expression. Although ATL can also be classified into TBX21 and GATA3 subtypes, the prognostic significance of this classification in ATL remains unclear. To evaluate the prognostic significance of the IHC-based classification of TBX21 and GATA3 subtypes in indolent ATL with cutaneous lesions, we performed a single-center, retrospective cohort study involving 47 patients with indolent ATL with cutaneous lesions. We estimated survival according to the patients' characteristics, including the IHC subtype, and assessed their prognostic significance. Patients with GATA3 subtype showed significantly worse survival than those with TBX21 subtype. In multivariate analyses, GATA3 subtype was identified as an independent prognostic factor for overall survival, along with older age, PCT type, and modified iATL-PI. GATA3 subtype was also independently associated with poorer progression-free survival, in addition to PCT type and modified iATL-PI. These results indicate that the IHC-based classification into TBX21 and GATA3 subtypes is useful for predicting survival and progression in indolent ATL patients with cutaneous lesions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.